If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.
Hi @Si_Derman, that website appears to lag significantly behind the official data on the Data Explorer (which I've linked a few times). However, I completely agree that the official website is extremely cumbersome to navigate, which is why I've been posting occasional updates instead.
There are currently 2 approved Heavy Sweet Oil (HSO) wells, of which one is now in drilling status. That other website seems to show only 1 currently approved as of now, which is inaccurate.
A reminder that "New Permit" means "You submitted the application, but no decision has been made yet".
Useful Screenshots:
- HSO Wells: https://ibb.co/rsG0871
- HSO 8-4 specifically: https://ibb.co/NrQw4Ls
Pilot project well HSO 8-4's status has now changed to "drilling", with the latest drilling report received on 10th May; I think it is fair to say that they're (finally) well under way now. Dry spud date is listed as 8th May.
> (despite posters here suggesting UK not attracting investment).
Respectfully that's a mischaracterisation, people said less attractive and not "not attracting investment".
Speaking for myself as one of those who commented on this topic: I am only interested in looking at the data, and do not want to get into an argument on any political or national pride angle; I'm not going to post flags or rhetoric.
And, I wouldn't dream of telling other people what to do, so please invest however you wish for your pension (or whatever) — it's a perfectly legitimate goal to prefer to invest in your home country with the idea that it might be beneficial to the economy.
I say that simply to clarify that it was not at all my intention to irritate anyone who may find the topic politically sensitive. I'm trying to keep it narrowly focussed on investing and what may optimise Quadrise's interests (and those of my other holdings that are currently in UK).
Here's the data:
Last 1 year
S&P 500 ARR 22%
FTSE 100 ARR 7.6%
Last 5 years:
S&P 500 ARR: 14%
FTSE 100 ARR: 5.7%
Last 10 years:
S&P 500 ARR: 15.8%
FTSE 100 ARR: 5.8%
You can see the data here (website chosen just because it had a cleaner design, I have no affiliation with it and I am not a customer). You will see similar patterns for other comparable indices.
https://curvo.eu/backtest/en/market-index/ftse-100?currency=gbp
https://curvo.eu/backtest/en/market-index/sp-500?currency=gbp
The reasons why are complicated, but a leading one is that many of the largest growing companies have been in the tech sector and many are based in US (or have been acquired by foreign companies — e.g. ARM).
You will also see similar patterns on how much money has been raised on the given exchanges, valuations, direction of acquisitions, etcetera.
@Peterrr, yes, agreed, good to see.
Ultimately, POLB is up approximately 25% since IPO, and although patience is required, I am very pleased with the quality and quantity of the development pipeline — plus a team with a good track record and the right expertise.
I am particularly enthused by POLB-001 and its application in therapy-induced CRS.
I do believe that POLB-001 could potentially be valuable in relapse/remitting autoimmune diseases where it could be used in short-term bursts to tamp down 'flares'.
In those cases, the issues around non-stop long-term use are greatly ameliorated, especially given it may avoid patients having to progress onto systemic steroid treatment.
Very interested to see where that goes in future.
Hi All,
I posted about this on The Quadrise Shareholders' Forum earlier, but I thought it might be interesting to quickly cross-post.
A second well from the Heavy Sweet Oil's (HSO) pilot project was finally approved by DOGM on 6th May — HSO 8-4
HSO 2-4, as I posted a little while ago, was formally permitted on 18th April.
Hopefully the remaining 2 wells from the pilot project are just a matter of time.
(NB: beware confusing US mm/dd/yyyy date formats when looking up any data).
@bertyb01, the exclusivity for Utah is on the cards, but nothing has been consummated. Currently they have a non-exclusive agreement.
From the circular (emphasis mine):
# Utah
The project with Valkor in Utah, USA, targets the supply of low sulphur MSAR® and bioMSAR™ to the
marine and power sectors, with the fuels produced on site then transported to major ports and power
stations.
In June 2023, QIL signed a Site License and Supply Agreement (“SLS”) with Valkor, under which QIL granted
Valkor the exclusive right and license to use our technology at a central processing facility located at the **Primary Project Site (“PPS”) at Asphalt Ridge in Utah, USA and to market the fuel on a non-exclusive basis
from Utah.**
In exchange, Valkor will pay QIL a US$1.0 million licence fee subject to receipt by Valkor of project financing
of at least US$15 million at the PPS. Valkor will pay QIL a further US$0.5 million upon delivery of an MMU
to the PPS.
Following Valkor’s receipt of the MMU, QIL will provide engineering, project development and support
services for a minimum of two years, for which Valkor will pay QIL a quarterly retainer of US$75,000 under
the SLS. Valkor may then choose to purchase QIL’s technology and MMU for US$1.0 million.
A non-binding Heads of Agreement has also been entered into between the parties which sets out the basis
on which **QIL and Valkor will seek to agree a conditionally exclusive Sub-License Agreement to be granted
to Valkor covering the state of Utah**, as well as the terms on which the resulting net profit generated will be
shared between QIL and Valkor
@Bing007, I believe this is referring to the recent Investor Meet Company (IMC) conference which featured Jeremy, David , and Tim. You can find a full replay on YouTube: https://www.youtube.com/watch?v=U8CoXkLLWRw
I recommend everyone block stt1. He shall remain a green box to me.
Sealion Singh is a poorly-educated liar, fraud, and loser who will go on parroting his lines despite having been thoroughly debunked on each and every occasion.
He's here to disrupt, annoy, and dissemble; he's not a good-faith actor. Such is the nature of the sealion https://en.wikipedia.org/wiki/Sealioning - engagement is his lifeblood.
Don't waste any of your weekend on him!
Assume that anything Singh says is a lie (misquotes; use of comments from other parties; outright fabrications; selective information).
Thanks, Brian.
Listing requirements are a complex topic; there are multiple standards, and they have very different mcap requirements depending on specific route taken. And NYSE vs NASDAQ rules are quite different. e.g. https://www.nyse.com/publicdocs/nyse/listing/NYSE_Initial_Listing_Standards_Summary.pdf
There is also the approach of reversing into an existing listing/shell, which was discussed as an option by management for a couple of the companies I hold.
To be clear, I am not predicting it's on the cards for QED; just agreeing with the previous comments that LSE has sadly dropped down the list in terms of ability to raise funds, poor valuations, and a lack of overall attractiveness. It's also sad to see some of its most famous constituents relist elsewhere.
I agree that Euronext listing could be an interesting option in distant future, if the company opts to remain independent. Too far into the future to be anything other than reading tea leaves.
Have a good long weekend, all.
A few UK stocks I holding are considering re-listing in US to get fairer valuations, more visibility and credibility, and better access to markets. Sadly, UK listings are not seen in the same way they used to be. It is a sensible thing for management teams to consider once they reach a certain size and sustainability.
> This strongly suggest to me the yacht is going to be built from scratch and will take a good 6 months until it is completed.
Is this timeline based on your extensive boatbuilding experience?
It is hard to figure out precisely what a realistic value for Quadrise is until the first deals are signed, revenues flow, and we see some formal results published. I think that's the first hurdle, but it will hopefully give us a very rough idea.
But there are several other important factors: it is highly likely that the first movers will negotiate and receive early adopter deals. And fair enough, they're being more forward-looking by acting as anchor customers, which benefits us. If that hypothesis is true, customers that come on board post-commercialisation could/should net Quarise better per-tonne revenues.
Another factor is that our products are also partly linked to commodity prices (conventional and bio), regulatory factors (CO2 trading), subsidies, etc. So, there'll naturally be quite a bit of variation.
In short, I think we can go from "thumb in air" to "ballpark" once first deals are signed and start flowing through, and then iteratively refine more accurate models and predictions that factor in the aspects discussed above.
Excellent IMC this evening. I was very impressed.
I really loved the enthusiasm of Dr. Coté (Tim).
My personal impression is that Tim is likely to come on board full time if a deal is struck for the Behçet's Disease candidate — with his world-leading expertise in orphan disease approvals [1], he'd be an absolutely perfect fit for Poolbeg's mission to bring this pipeline of candidates that fulfil unmet needs to market in a timely fashion. He also seemed to have a really good rapport with Jeremy and David.
This looks like an excellent additional string to our bow, and Tim could add in-house capabilities across the board that are extremely valuable to the company (regulatory, medical, orphan drug, autoimmunity, etc).
Progress on POLB 001 has been strong, and it's clear there is a huge unmet need for a way to safely mitigate and treat immunotherapy-induced CRS. This seems like it could be a slam-dunk if the trials pan out as expected.
As other folk here have alluded to in recent times, patience is required, but there's a very strong pipeline building and the fiscal discipline means there's plenty of runway available.
[1] He worked for the FDA in orphan disease approvals and has written innumerable applications.
I notice HVO holders fighting back by posting on the (Totally) TLY board. Can I suggest people stop bothering posting there?
It is merely encouraging stt1/Singh to continue with his tit-for-tat nonsense as revenge for dunking on one of his favourite stocks.
Anyway, no more on Singh!
I hope all HVO holders have a great weekend. Fingers crossed for the first spell of decent weather this year.
From Trio Petroleum Corp: https://ir.trio-petroleum.com/press-releases/?qmodStoryID=8770630253578057
"""
The Company is also announcing the commencement of drilling activities on the Asphalt Ridge project in Uintah County, UT. A rig is scheduled to be on site this Sunday, and to drill and complete the Company’s first well on this asset in the next two weeks. Drilling results are expected to be readily available shortly after the well is drilled to a total estimated depth of 1,200 feet. The project targets a highly promising heavy-oil tar sand field that is expected to be densely developed at scale, with as low as 2.5 acre spacing for future wells. Through existing working interests and option agreements, the Company has the ability to take up to a 20% working interest in this project.
“These are positive next milestones for our Company,” commented Michael Peterson, CEO of Trio Petroleum Corp. “It is very encouraging to see these next steps happen in the transition from the exploration and de-risking of these promising oil and gas assets into potentially scalable cash-flowing resources. We look forward to providing further updates as we drill our first well on the Asphalt Ridge Asset and restart production on additional wells and selling of oil produced from both the McCool Ranch and Presidents Fields in the months ahead.”
"""
(References to McCool Ranch and Presidents Ranch are not related to the Utah project)
Valkor not Valcor.
Valcor is a completely different engineering company.
[And The Valkor Group more broadly*]
I personally do not find TomCo credible any more after their antics with "funding by Easter" for 3-odd years, and brutally diluting shareholders on a regular basis.
I think Heavy Sweet Oil are the company to pay attention to.
Elements of common ownership/leadership. Steve Byle founded/cofounded the various companies involved (Valkor, Crosstrails, HSO, etc).
Thanks, @BurtonD for the link. 35-40p seems eminently achievable in the medium term based on a comparison with HVO's CRO peers (P/S, P/E, EBITDA, margin, forward revenue visibility, excellent business plan, high barrier to entry for competitors, etc).
I'm delighted to have HVO as a core holding in my portfolio — its consistent delivery has been absolutely wonderful.
Those attributes do make one wonder whether we will become a target for takeover at some point.